Nexsen Limited (ASX:NXN) Filings

Nexsen Limited

Filings

FilingDateTypeFiled with
Proposed issue of securities - NXNNov 20, 2026FinancingASX
Nexsen Appointments to Advisory BoardNov 15, 2026Other filingsASX
A$1.2 million R&D Tax Incentive refund receivedNov 12, 2026ResultsASX
Results of MeetingNov 9, 2026Meeting outcomeASX
Nexsen advances kidney diagnostics programNov 5, 2026Other filingsASX
Co Secretary Appoint/Resign and Change of Registered AddressNov 2, 2026Other filingsASX
ISO 13485 Certification brings StrepSure closer to marketNov 1, 2026Operations updateASX
Quarterly Report - Q1 FY27Oct 27, 2026Quarterly reportASX
Quarterly Report - Q1 FY27Oct 27, 2026Quarterly reportASX
Notice of AGM and Meeting MaterialsOct 7, 2026Meeting noticeASX
Professor Shekhar Kumta appointed Executive DirectorSep 30, 2026Management or board changeASX
Reinstatement to QuotationSep 24, 2026Trading halt or suspensionASX
Proposed FlashDx joint venture builds on CE-marked GBS testSep 24, 2026Operations updateASX
Suspension from QuotationSep 23, 2026Trading halt or suspensionASX
Clear pathway defined to optimise StrepSureSep 23, 2026Operations updateASX
Trading HaltSep 21, 2026Trading halt or suspensionASX
Director Interest Notices re Performance RightsSep 10, 2026Ownership change noticeASX
Notification regarding unquoted securities - NXNSep 10, 2026Other filingsASX
Notification regarding unquoted securities - NXNSep 10, 2026Other filingsASX
Annual Report - FY 2026Aug 30, 2026Annual reportASX
Corporate Governance Statement and Appendix 4GAug 30, 2026Other filingsASX
Quarterly Report - Q4 FY26Jul 28, 2026Quarterly reportASX
$1.5m non-dilutive ARC funding for manufacturingJun 24, 2026FinancingASX
Nexsen secures first hospital partner in AsiaMay 12, 2026Operations updateASX
Nexsen and Universiti Malaya launch joint facilityMay 3, 2026Operations updateASX
Quarterly Report - Q3 FY26Apr 27, 2026Quarterly reportASX
QMS milestone achievedApr 6, 2026Operations updateASX
HK$6 million grant awarded to advance Asia-Pacific executionMar 30, 2026Operations updateASX
Nexsen accelerates global rollout for StrepSureMar 25, 2026Operations updateASX
FDA feedback derisks US approval pathway for StrepSureMar 22, 2026Operations updateASX
Half Yearly Report and AccountsFeb 26, 2026Interim reportASX
Quarterly Report - Q2 FY26Jan 29, 2026Quarterly reportASX
$500k govt grant expands GBS project to neonatesJan 26, 2026Operations updateASX
Investor PresentationDec 7, 2025Other filingsASX
Nexsen Appoints Global Clinical Leader to the BoardDec 2, 2025Management or board changeASX
Quarterly Report - Q1 FY26Oct 31, 2025Quarterly reportASX
Nexsen launches clinical trial for GBS Rapid SensorOct 20, 2025Operations updateASX